Full Text
The Full Text of this article is available as a PDF (27.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Davidson J. R., DuPont R. L., Hedges D., Haskins J. T. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry. 1999 Aug;60(8):528–535. doi: 10.4088/jcp.v60n0805. [DOI] [PubMed] [Google Scholar]
- Flint A. J. Management of anxiety in late life. J Geriatr Psychiatry Neurol. 1998 Winter;11(4):194–200. doi: 10.1177/089198879901100405. [DOI] [PubMed] [Google Scholar]
- Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J., Gavaghan D. J., McQuay H. J. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996 Feb;17(1):1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
- Stahl S. M. Antidepressants: the blue-chip psychotropic for the modern treatment of anxiety disorders. J Clin Psychiatry. 1999 Jun;60(6):356–357. doi: 10.4088/jcp.v60n0601. [DOI] [PubMed] [Google Scholar]